Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Financing Activities: 2010-2023

Historic Cash from Financing Activities for SRx Health Solutions (SRXH) over the last 14 years, with FY2023 value amounting to -$5.1 million.

  • SRx Health Solutions' Cash from Financing Activities fell 1788.6% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.9 million, marking a year-over-year increase of 3482.73%. This contributed to the annual value of -$5.1 million for FY2023, which is 49758.19% down from last year.
  • SRx Health Solutions' Cash from Financing Activities amounted to -$5.1 million in FY2023, which was down 49758.19% from $1.3 million recorded in FY2022.
  • In the past 5 years, SRx Health Solutions' Cash from Financing Activities registered a high of $39.8 million during FY2019, and its lowest value of -$5.1 million during FY2023.
  • Its 5-year average for Cash from Financing Activities is $16.4 million, with a median of $9.1 million in 2020.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 30790.25% in 2021, then crashed by 49758.19% in 2023.
  • Annual analysis of 5 years shows SRx Health Solutions' Cash from Financing Activities stood at $39.8 million in 2019, then tumbled by 77.09% to $9.1 million in 2020, then skyrocketed by 307.9% to $37.2 million in 2021, then crashed by 96.55% to $1.3 million in 2022, then tumbled by 497.58% to -$5.1 million in 2023.
  • Its Cash from Financing Activities stands at -$5.1 million for FY2023, versus $1.3 million for FY2022 and $37.2 million for FY2021.